REVIEW ARTICLE The interplay of microRNAs and post-ischemic glutamate excitotoxicity: an emergent research field in stroke medicine Alireza Majdi 1 • Javad Mahmoudi 1 • Saeed Sadigh-Eteghad 1 • Mehdi Farhoudi 1 • Siamak Sandoghchian Shotorbani 2 Received: 6 March 2016 / Accepted: 20 June 2016 Ó Springer-Verlag Italia 2016 Abstract Stroke is the second leading cause of death and the most common cause of adult disabilities among elder- lies. It involves a complex series of mechanisms among which, excitotoxicity is of great importance. Also, miRNAs appear to play role in post-stroke excitotoxicity, and changes in their transcriptome occur right after cerebral ischemia. Recent data indicate that specific miRNAs such as miRNA-223, miRNA-181, miRNA-125a, miRNA-125b, miRNA-1000, miRNA-132 and miRNA-124a regulate glutamate neurotransmission and excitotoxicity during stroke. However, limitations such as poor in vivo stability, side effects and inappropriate biodistribution in miRNA- based therapies still exist and should be overcome before clinical application. Thence, investigation of the effect of application of these miRNAs after the onset of ischemia is a pivotal step for manipulating these miRNAs in clinical use. Given this, present review concentrates on miRNAs roles in post-ischemic stroke excitotoxicity. Keywords Ischemic stroke Glutamate excitotoxicity MicroRNA NMDA receptors AMPA receptors Introduction Stroke is the second leading cause of death, the second most common cause of dementia and the most common cause of adult disabilities among elderlies [1–3]. Globally, it is responsible for nearly 5.5 million deaths every year, with 44 million disability-adjusted life-years lost which will increase up to 61 million in 2020 [2, 4]. Of this, ischemic stroke accounts for approximately 73 to 86 %, whereas hemorrhagic stroke is responsible for 8 to 18 % of the cases [5]. Brain ischemia initiates a cascade of pathological events that finally lead to irreversible neuronal damage [6]. It involves a complex series of biological and molecular mechanisms such as excitotoxicity, oxidative stress, inflammation, ionic imbalance, blood–brain barrier dis- ruption and apoptosis [7, 8]. Among these mechanisms, excitotoxicity is notable. It is mainly a glutamate-mediated specific type of neurotoxicity and is the overlooked link between ischemic stroke and neuronal damage and cell death [9]. It stems from excessive accumulation of exci- tatory amino acids such as glutamate and leads to toxic increases in intracellular calcium [7, 10] which mediates neuronal damage in stroke [11]. miRNAs are small (*19 to 23 nucleotides) noncoding endogenous molecules that bind messenger RNAs (mRNA) and promote their degradation or repression of translation [12]. They have been found to be responsible for neuronal differentiation and development [6] and their role as mediators of silencing of post-transcriptional gene in pathological aspects of ischemic stroke has been proved [13]. Changes in the microRNAs (miRNA) transcriptome occur right after focal cerebral ischemia which indicates miRNAs role in the pathological cascades of ischemic stroke [13–15]. Alteration in miRNAs level after brain ischemic injury was first noticed in focal brain and fore- brain ischemia and recent studies have assessed the sig- nificance of local changes in miRNA expression level [12, 16]. Furthermore, microRNAs aberrant, both up and down, regulation has been reported during cerebral & Javad Mahmoudi javadmahmoudi1992@yahoo.com 1 Neurosciences Research Center (NSRC), Tabriz University of Medical Sciences, P.O. Box: 5166614756, Tabriz, Iran 2 Department of Immunology, Tabriz Branch, Islamic Azad University, Tabriz, Iran 123 Neurol Sci DOI 10.1007/s10072-016-2643-5